Based on current evidence, only a subset of genes have been confirmed to be strongly associated with SQTS; according to the Clinical Genome Resource (ClinGen), genes such as KCNH2, KCNQ1, KCNJ2, and SLC4A3 are considered to have sufficient evidence for their inclusion in genetic testing panels. This evidence concerns the gene KCNH2 and Familial short QT syndrome.